In February 2020, STORZ MEDICAL has received the CE approval for the MAGNETOLITH® system, which is the successor of the CELLACTOR® MT1. Extracorporeal Magnetotransduction Therapy (EMTT®) with the MAGNETOLITH® opens up new possibilities in regeneration and rehabilitation. The areas of application include diseases of the musculoskeletal system such as lower back pain and tendinopathies of the rotator cuff or Achilles tendon. The non-invasive, outpatient therapy is virtually free of side effects.
EMTT® differs from general forms of magnetic field therapy or PEMF due to the high oscillation frequency of 100 – 300 kHz. This property enables a high penetration depth (18 cm) and a large range of indications.
Treatment with the MAGNETOLITH® system is comfortable and straightforward:
MAGNETOLITH / Static treatment of shoulder with holding arm
EMTT® Highlights
Typical indications of EMTT®
Musculoskeletal diseases
Further information on the new MAGNETOLITH® is available on our website
By accepting you will be accessing a service provided by a third-party external to https://www.storzmedical.com/